{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:48Z","timestamp":1792189188225,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jilin Province Health Science and Technology Capacity Improvement Project","award":["2021JC001"],"award-info":[{"award-number":["2021JC001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11235-4","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:17:03Z","timestamp":1751375823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Differentiation of Pneumocystis jirovecii pneumonia from colonization: a clinical decision framework incorporating risk stratification and next-generation sequencing thresholds"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaoyan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"2","key":"11235_CR1","doi-asserted-by":"publisher","first-page":"e0020222","DOI":"10.1128\/mmbr.00202-22","volume":"88","author":"OH Ciss\u00e9","year":"2024","unstructured":"Ciss\u00e9 OH, Ma L, Kovacs JA. Retracing the evolution of Pneumocystis species, with a focus on the human pathogen Pneumocystis jirovecii [J]. Microbiol Mol Biol Rev. 2024;88(2):e0020222.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"4","key":"11235_CR2","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jinf.2023.02.014","volume":"86","author":"K Pates","year":"2023","unstructured":"Pates K, Periselneris J, Russell MD, et al. Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England [J]. J Infect. 2023;86(4):385\u201390.","journal-title":"J Infect"},{"key":"11235_CR3","first-page":"172","volume":"121","author":"G Bozzi","year":"2022","unstructured":"Bozzi G, Saltini P, Matera M, et al. Pneumocystis jirovecii pneumonia in HIV-negative patients, a frequently overlooked problem. A case series from a large Italian center [J]. Int J Infect Diseases: IJID: Official Publication Int Soc Infect Dis. 2022;121:172\u20136.","journal-title":"Int J Infect Diseases: IJID: Official Publication Int Soc Infect Dis"},{"issue":"1","key":"11235_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000487713","volume":"96","author":"HJF Salzer","year":"2018","unstructured":"Salzer HJF, Sch\u00e4fer G, Hoenigl M, et al. Clinical, diagnostic, and treatment disparities between HIV-Infected and Non-HIV-Infected immunocompromised patients with Pneumocystis jirovecii pneumonia [J]. Respiration. 2018;96(1):52\u201365.","journal-title":"Respiration"},{"key":"11235_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/IDR.S444571","volume":"17","author":"M-Q Huang","year":"2024","unstructured":"Huang M-Q, Zheng T-T, Wang X-R, et al. The clinical value of metagenomic next-generation sequencing in Pneumocystis jirovecii pneumonia [J]. Infect Drug Resist. 2024;17:69\u201380. https:\/\/doi.org\/10.2147\/IDR.S444571.","journal-title":"Infect Drug Resist"},{"issue":"9","key":"11235_CR6","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1093\/jac\/dkw156","volume":"71","author":"A Alanio","year":"2016","unstructured":"Alanio A, Hauser PM, Lagrou K, et al. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients [J]. J Antimicrob Chemother. 2016;71(9):2386\u201396.","journal-title":"J Antimicrob Chemother"},{"issue":"24","key":"11235_CR7","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1001\/jama.2009.880","volume":"301","author":"JA Kovacs","year":"2009","unstructured":"Kovacs JA, Masur H. Evolving health effects of pneumocystis: one hundred years of progress in diagnosis and treatment [J]. JAMA. 2009;301(24):2578\u201385.","journal-title":"JAMA"},{"key":"11235_CR8","doi-asserted-by":"publisher","first-page":"994175","DOI":"10.3389\/fcimb.2022.994175","volume":"12","author":"JN Hou","year":"2022","unstructured":"Hou JN, Liu HD, Tan QY, et al. Risk factors of in-hospital mortality in patients with Pneumocystis pneumonia diagnosed by metagenomics next-generation sequencing [J]. Front Cell Infect Microbiol. 2022;12:994175.","journal-title":"Front Cell Infect Microbiol"},{"key":"11235_CR9","doi-asserted-by":"publisher","unstructured":"Liu Y, Wu W, Xiao Y, et al. Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients [J]. Front Cell Infect Microbiol. 2024;14:1439472. https:\/\/doi.org\/10.3389\/fcimb.2024.1439472.","DOI":"10.3389\/fcimb.2024.1439472"},{"key":"11235_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fpubh.2019.00275","volume":"7","author":"E Pereira-D\u00edaz","year":"2019","unstructured":"Pereira-D\u00edaz E, Moreno-Verdejo F, de la Horra C, et al. Changing trends in the epidemiology and risk factors of Pneumocystis pneumonia in Spain [J]. Front Public Health. 2019;7:275.","journal-title":"Front Public Health"},{"key":"11235_CR11","doi-asserted-by":"publisher","first-page":"100400","DOI":"10.1016\/j.lanepe.2022.100400","volume":"18","author":"B Kolbrink","year":"2022","unstructured":"Kolbrink B, Scheikholeslami-Sabzewari J, Borzikowsky C, et al. Evolving epidemiology of Pneumocystis pneumonia: findings from a longitudinal population-based study and a retrospective multi-center study in Germany [J]. Lancet Reg Health Eur. 2022;18:100400.","journal-title":"Lancet Reg Health Eur"},{"issue":"7","key":"11235_CR12","doi-asserted-by":"publisher","first-page":"e101943","DOI":"10.1371\/journal.pone.0101943","volume":"9","author":"F Guo","year":"2014","unstructured":"Guo F, Chen Y, Yang SL, et al. Pneumocystis pneumonia in HIV-infected and immunocompromised non-HIV infected patients: a retrospective study of two centers in China [J]. PLoS ONE. 2014;9(7):e101943.","journal-title":"PLoS ONE"},{"issue":"1","key":"11235_CR13","doi-asserted-by":"publisher","first-page":"9226","DOI":"10.1038\/s41598-021-88729-z","volume":"11","author":"R Sun","year":"2021","unstructured":"Sun R, Lv D, Xiao M, et al. Diagnostic accuracy of the 1,3-beta-D-glucan test and lactate dehydrogenase for Pneumocystis pneumonia in non-HIV patients [J]. Sci Rep. 2021;11(1):9226.","journal-title":"Sci Rep"},{"issue":"4","key":"11235_CR14","doi-asserted-by":"publisher","first-page":"e3791","DOI":"10.1016\/j.cmi.2014.11.025","volume":"21","author":"F Esteves","year":"2015","unstructured":"Esteves F, Cal\u00e9 SS, Badura R, et al. Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers [J]. Clin Microbiol Infect. 2015;21(4):e3791\u201310.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"11235_CR15","first-page":"322","volume":"30","author":"C Deng","year":"2018","unstructured":"Deng C, Li Y, Li Y. [Systemic review: the accuracy of lactic dehydrogenase in the diagnosis of Pneumocystis pneumonia] [J]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018;30(4):322\u20136.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"12","key":"11235_CR16","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer\/invasive fungal infections cooperative group and the National Institute of allergy and infectious diseases mycoses study group (EORTC\/MSG) consensus group [J]. Clin Infect Dis. 2008;46(12):1813\u201321.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"11235_CR17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.cmi.2020.05.024","volume":"26","author":"O Del Corpo","year":"2020","unstructured":"Del Corpo O, Butler-Laporte G, Sheppard DC, et al. Diagnostic accuracy of serum (1\u20133)-\u03b2-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis [J]. Clin Microbiol Infect. 2020;26(9):1137\u201343.","journal-title":"Clin Microbiol Infect"},{"key":"11235_CR18","doi-asserted-by":"publisher","first-page":"784236","DOI":"10.3389\/fcimb.2021.784236","volume":"11","author":"L Liu","year":"2021","unstructured":"Liu L, Yuan M, Shi Y, et al. Clinical performance of BAL metagenomic Next-Generation sequence and serum (1,3)-\u03b2-D-Glucan for differential diagnosis of Pneumocystis jirovecii pneumonia and Pneumocystis jirovecii colonisation [J]. Front Cell Infect Microbiol. 2021;11:784236.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"11235_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.3390\/jof8070663","volume":"8","author":"J Bigot","year":"2022","unstructured":"Bigot J, Vellaissamy S, Senghor Y, et al. Usefulness of \u00df-d-Glucan assay for the First-Line diagnosis of Pneumocystis pneumonia and for discriminating between Pneumocystis colonization and Pneumocystis pneumonia [J]. J Fungi (Basel). 2022;8(7):663. https:\/\/doi.org\/10.3390\/jof8070663.","journal-title":"J Fungi (Basel)"},{"issue":"4","key":"11235_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.cmi.2024.11.004","volume":"31","author":"C Prosty","year":"2025","unstructured":"Prosty C, Luo OD, Khalaf R, et al. Diagnostic test accuracy of the fungitell serum (1\u21923)-\u03b2-D-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis [J]. Clin Microbiol Infect. 2025;31(4):542\u201350.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"11235_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12879-023-08440-4","volume":"23","author":"X Li","year":"2023","unstructured":"Li X, Li Z, Ye J, et al. Diagnostic performance of metagenomic next-generation sequencing for Pneumocystis jirovecii pneumonia [J]. BMC Infect Dis. 2023;23(1):455.","journal-title":"BMC Infect Dis"},{"key":"11235_CR22","doi-asserted-by":"publisher","first-page":"694756","DOI":"10.3389\/fcimb.2021.694756","volume":"11","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Qiu X, Wang T, et al. The diagnostic value of metagenomic Next-Generation sequencing in lower respiratory tract infection [J]. Front Cell Infect Microbiol. 2021;11:694756.","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"11235_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s11046-024-00849-y","volume":"189","author":"F Xing","year":"2024","unstructured":"Xing F, Deng C, Luo Z, et al. Rapid diagnosis of Pneumocystis jirovecii pneumonia and respiratory tract colonization by Next-Generation sequencing [J]. Mycopathologia. 2024;189(3):38.","journal-title":"Mycopathologia"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11235-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11235-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11235-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:17:04Z","timestamp":1751375824000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11235-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11235"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11235-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study adheres to the Declaration of Helsinki. The study protocol was approved by the Institutional Review Board of The First Hospital of Jilin University (Approval No. 2024-720).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"874"}}